Recent Developments in Comprehensive Approaches for Managing Solitary Fibrous Tumors of the Central Nervous System
By
Zhongxin Yang
Xun Xia
July 6, 2026
Clinical Scorecard: Recent Developments in Comprehensive Approaches for Managing Solitary Fibrous Tumors of the Central Nervous System
At a Glance
Category Detail
Condition Solitary Fibrous Tumors of the Central Nervous System Key Mechanisms Surgical resection, postoperative radiotherapy, anti-angiogenic therapy, immunotherapy. Target Population Patients with solitary fibrous tumors of the CNS. Care Setting Specialized sarcoma treatment centers.
Key Highlights
Surgical resection is the primary treatment, but gross-total resection is often challenging. Postoperative recurrence rates can be as high as 43%. Anti-angiogenic agents like pazopanib show superior disease control compared to conventional chemotherapy. Immunotherapy has shown limited but promising activity in select patients. Multidisciplinary team approach is essential for optimal patient management. Guideline-Based Recommendations
Diagnosis
Utilize a multidisciplinary team for individualized treatment plans. Management
Maximal safe surgical resection is the cornerstone of local control. Postoperative radiotherapy can improve local control rates for high-risk patients. Monitoring & Follow-up
Lifelong, regular MRI surveillance is crucial for early detection of recurrence. Risks
Postoperative recurrence and metastasis are significant risks. Patient & Prescribing Data
Patients with advanced, recurrent, or metastatic non-dedifferentiated SFT.
Cytotoxic chemotherapy is reserved for refractory or dedifferentiated subtypes.
Clinical Best Practices
Employ combined use of RECIST and Choi criteria for treatment efficacy assessment. Related Resources & Content
